BioSpace News Archive

Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer and infectious disease immunotherapies, and Genevant Sciences, a leading nucleic acid delivery company with world-class platforms and the industry’s most robust and expansive lipid nanoparticle (LNP)

Verastem, Inc. (Nasdaq:VSTM) (also known as Verastem Oncology), a biopharmaceutical company committed to advancing new medicines for patients battling cancer, today announced the departure of the Company’s Chief Medical Officer, Frank Neumann, M.D., Ph.D., effective immediately.

Biophytis SA, a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases, including severe respiratory failure in patients suffering from COVID-19, announces that it has publicly filed yesterday after closing of the market in Paris a registration statement on Form F-1 with the U.S.

Antihistamines are a class of drugs that inhibit the action of histamine by attacking the specific cell receptors meant for histamines.

Healthcare physician staffing majorly refers to outsourcing of healthcare physician staff by third party vendors to the healthcare units. The facility helps healthcare units to avail staff without indulging into long recruitment process.

A recent report published by Fact.MR divides the global medical marker bands in five key regional segments.

In simple terms, refractory angina is a disabling chronic heart pain, as a result of heart disease.

Neuronascent Inc., a privately-held neuron regeneration therapeutics company, announced the publication of results of their novel pharmacotherapy: NNI-362 to allosterically stimulate neural regeneration in human cultures and in vivo models of aging and disease.

Fundamental execution was strong across UnitedHealth Group in the fourth quarter and throughout the full year 2020, led by Optum and by UnitedHealthcare’s community and senior benefit businesses, even as the Company delivered expansive voluntary relief efforts for consumers, care providers and customers across the health system.

Charles Strongo, CEO of Global WholeHealth Partners Corp (GWHP-OTC), comments on https://www.cbsnews.com/news/covid-death-toll-united-states-expected-500k-february/ regarding the potential of 500,000 deaths by mid-February, as stated by the incoming director of the Centers for Disease Control.